Paper41005301
Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques.
Styles TM and 27 others. Cell Rep Med, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques. Papers, record 41005301. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41005301
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Influenza Vaccines | Major topic |
| Plasma Cells | Major topic |
| RNA, Messenger | Major topic |
| Bone Marrow Cells | Major topic |
| Hemagglutinin Glycoproteins, Influenza Virus | Major topic |
| Animals | |
| Macaca mulatta | |
| Mice | |
| Antibodies, Viral | |
| Nanoparticles | |
| Female | |
| mRNA Vaccines | |
| Orthomyxoviridae Infections | |
| Immunity, Humoral | |
| Cytokines | |
| Liposomes |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 75N93019C00051 | NIAID NIH HHS | United States | PubMed | PubMed | |
| R01 AI146101 | NIAID NIH HHS | United States | R01AI146101 | PubMed and NIH | NIH RePORTER |
| R01 AI153064 | NIAID NIH HHS | United States | R01AI153064 | PubMed and NIH | NIH RePORTER |
References129
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34942633 | Broadly neutralizing antibodies target a haemagglutinin anchor epitope. | Nature | 2022 | https://conductscience.org/library/papers/34942633 | PubMed |
| 2 | 27453466 | Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes. | Cell | 2016 | https://conductscience.org/library/papers/27453466 | PubMed |
| 3 | 30224494 | Influenza hemagglutinin membrane anchor. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30224494 | PubMed |
| 4 | 34516743 | PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8+ T cells in lymphoid tissue. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34516743 | PubMed |
| 5 | 22328912 | Interferon-stimulated genes and their antiviral effector functions. | Curr Opin Virol | 2011 | https://conductscience.org/library/papers/22328912 | PubMed |
| 6 | 37011668 | SARS-CoV-2 Omicron boosting induces de novo B cell response in humans. | Nature | 2023 | https://conductscience.org/library/papers/37011668 | PubMed |
| 7 | 34117252 | SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung. | Nat Commun | 2021 | https://conductscience.org/library/papers/34117252 | PubMed |
| 8 | 37516970 | Protocol for analyzing antibody responses to glycoprotein antigens using electron-microscopy-based polyclonal epitope mapping. | STAR Protoc | 2023 | https://conductscience.org/library/papers/37516970 | PubMed |
| 9 | 2310829 | Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. | Blood | 1990 | https://conductscience.org/library/papers/2310829 | PubMed |
| 10 | 16111635 | Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. | Immunity | 2005 | https://conductscience.org/library/papers/16111635 | PubMed |
| 11 | 28958808 | Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system. | Vaccine | 2017 | https://conductscience.org/library/papers/28958808 | PubMed |
| 12 | 7547435 | Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. | Int J Exp Pathol | 1995 | https://conductscience.org/library/papers/7547435 | PubMed |
| 13 | 30150460 | Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/30150460 | PubMed |
| 14 | 18797453 | Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. | Mol Ther | 2008 | https://conductscience.org/library/papers/18797453 | PubMed |
| 15 | 35672369 | Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection. | Nat Commun | 2022 | https://conductscience.org/library/papers/35672369 | PubMed |
| 16 | 21508344 | Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. | Arterioscler Thromb Vasc Biol | 2011 | https://conductscience.org/library/papers/21508344 | PubMed |
| 17 | 35332327 | IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. | Nat Immunol | 2022 | https://conductscience.org/library/papers/35332327 | PubMed |
| 18 | 31839997 | Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts. | NPJ Vaccines | 2019 | https://conductscience.org/library/papers/31839997 | PubMed |
| 19 | 35924920 | Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques. | J Virol | 2022 | https://conductscience.org/library/papers/35924920 | PubMed |
| 20 | 33093657 | Self-amplifying RNA vaccines for infectious diseases. | Gene Ther | 2021 | https://conductscience.org/library/papers/33093657 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42944074 | Immune Imprinting Across Respiratory Virus Infection, Vaccination, and Passive Immunization: Rethinking 'Original Antigenic Sin' in Influenza, SARS-CoV-2, and RSV. | Viruses | 2026 | https://conductscience.org/library/papers/42944074 | PubMed |
| 41646968 | Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine. | Front Immunol | 2025 | https://conductscience.org/library/papers/41646968 | PubMed |
| 41256048 | Preparing for the Next Influenza Pandemic: Vaccine Progress, Challenges, and Prospects. | China CDC Wkly | 2025 | https://conductscience.org/library/papers/41256048 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41005301
GET https://conductscience.org/api/papers/v1/41005301/authors?page=2